SRIVASSO RESPIMAT tiotropium 2.5 micrograms/actuation solution for inhalation cartridge (with dose indicator)

Land: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

tiotropium bromide monohydrate, Quantity: 3.1235 microgram/actuation (Equivalent: tiotropium, Qty 2.5 microgram/actuation)

Fáanlegur frá:

Boehringer Ingelheim Pty Ltd

Lyfjaform:

Inhalation, conventional

Samsetning:

Excipient Ingredients: purified water; hydrochloric acid; disodium edetate; benzalkonium chloride

Stjórnsýsluleið:

Inhalation

Einingar í pakka:

3 x 1 cartridge (60 metered actuations) with dose indicator, 1 cartridge (60 metered actuations) with dose indicator

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

COPD: SRIVASSO RESPIMAT is indicated for the long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (COPD). SRIVASSO RESPIMAT is indicated for the prevention of COPD exacerbations.,Asthma: SRIVASSO RESPIMAT is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with moderate to severe asthma.

Vörulýsing:

Visual Identification: Clear, colourless solution.; Container Type: Cartridge; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Leyfisstaða:

Registered

Leyfisdagur:

2020-03-04